Source: Virtual Congress 2021 – COVID - 19



Rating:

Share or cite this content

Citations should be made in the following way:
E. Antonogiannaki (Athens, Greece), K. Thomas (Athens, Greece), D. Kavatha (Athens, Greece), E. Manali (Athens, Greece), D. Konstantonis (Athens, Greece), N. Arkoudis (Athens, Greece), A. Tsochatzis (Athens, Greece), P. Kazakou (Athens, Greece), S. Grigoropoulou (Athens, Greece), C. Psarrakis (Athens, Greece), M. Paneta (Athens, Greece), M. Kallieri (Athens, Greece), C. Oikonomopoulou (Athens, Greece), S. Loukidis (Athens, Greece), A. Antoniadou (Athens, Greece), S. Papiris (Athens, Greece). COVID-19: the day after. 3478

Member's Comments

No comment yet.

Related content which might interest you: Reslizumab: Effectiveness one month after first dose. Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma Year: 2020 General discussion: Day 2 Source: Course 2015 - Clinical exercise testing Year: 2015 General discussion: Day 1 Source: Course 2015 - Clinical exercise testing Year: 2015 What represents a meaningful improvement in symptom-free days (SFD) and rescue-free days (RFD)? The patient‘s perspective Source: Annual Congress 2010 - Management of airway disease Year: 2010 LATE-BREAKING ABSTRACT: RESPIRE 1: Ciprofloxacin DPI 32.5mg b.d. administered 14 day on/off or 28 day on/off vs placebo for 48 weeks in subjects with non-cystic fibrosis bronchiectasis (NCFB) Source: International Congress 2016 – Clinical update on bronchiectasis Year: 2016 The effect of two month's treatment with fluticasone (F) at a dose of 500 mg per day versus fluticasone at a dose of 250 mg per day plus salmeterol (S) 100 mg per day in patients with moderate asthma Source: Eur Respir J 2002; 20: Suppl. 38, 302s Year: 2002 Day 1 highlights Source: Sleep and Breathing Conference 2021 Year: 2021 Dose selection and pharmacokinetics of montelukast (sprinkles) in >=6 month to <2 year old asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 525s Year: 2002 Rare (pulmonary) disease day: “feeding the breath, energy for life!” Source: Eur Respir J 2015; 45: 297-300 Year: 2015 Influence of an incentive spacer on adherence to prescribed treatment in 2-6 year old children over a 3 month period Source: Annual Congress 2007 - Childhood asthma: treatment and follow-up Year: 2007 Non-smoking day activities Source: Eur Respir J 2005; 26: Suppl. 49, 155s Year: 2005 A seven week out patient pulmonary rehabilitation programme versus a four week out patient pulmonary rehabilitation programme: results at six months Source: Eur Respir J 2005; 26: Suppl. 49, 68s Year: 2005 Pulmonary function 45 and 180 days after COVID-19 hospitalization: does time, in fact, heal all wounds? Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation Year: 2021 COVID-19: Is pulmonary damage present after 10 weeks follow-up? Source: Virtual Congress 2021 – Chronic COVID - 19 Year: 2021 Asthma control evaluation in every day practice: room for improvement? Source: Eur Respir J 2003; 22: Suppl. 45, 536s Year: 2003 Oxygen prescription: has it changed over the last 4 years? Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients Year: 2009 Bronchial epithelium changes occurring between the 2nd and the 5th post-biopsy day Source: Eur Respir J 2002; 20: Suppl. 38, 77s Year: 2002